Why is Fermenta Biotec. falling/rising?

As of 26-Sep, Fermenta Biotech Ltd's stock price is currently at 314.55, reflecting a decline of 11.9 points or 3.65%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 6.38% during this period. It has also underperformed its sector by 1.31%. The stock is trading below its moving averages across various time frames, indicating a bearish trend. Despite the company reporting very positive results in June, including a significant growth in operating profit and consistent positive quarterly results, the stock's performance has been hindered by weak long-term fundamentals and a lack of investor confidence, as evidenced by a low delivery volume.
In the broader market context, Fermenta Biotech's short-term performance has been notably worse than the benchmark, with a 1-week return of -6.61% compared to the Sensex's -2.66%. This disparity highlights the stock's struggle relative to the overall market. While the company has shown strong growth metrics and has outperformed the BSE500 in the long term, the lack of domestic mutual fund investment and concerns over long-term growth prospects may be contributing to its current decline. The pharmaceuticals and drugs sector has also seen a decline of 2.35%, further impacting investor sentiment towards Fermenta Biotech.